Gene joined the firm in 2001 and qualified in 2003. He was appointed a partner in 2010.
He has a particular expertise in clinical trials and product safety. Gene represented over 200 British military veterans exposed to chemical warfare agents, allegedly without their informed consent, at the Porton Down military laboratories from the 1940s -1980s.
In 2009, he successfully resolved the claims of four of the clinical volunteers who suffered life threatening injuries as participants in the infamous TGN1412 drug trial at Northwick Park Hospital.
More recently, Gene has been instructed by Mr Hailer who, following his participation in a clinical drug trial, alleges he suffered a significant brain injury. The drug in question was manufactured by Novartis.
Gene currently leads the firm's group litigation regarding the Zimmer Durom hip replacement components (in which the Court has ordered that Leigh Day be appointed Lead Solicitors for the Claimants) and previously worked on the successful DePuy Hylamer group litigation relating to defective hip replacements.
He has also resolved a number of cases involving defective heart valves, pacemakers and connecting leads. Gene currently represents a client who alleges that a St Jude Medical Deep Brain Stimulator failed before it should have.
Gene currently leads a claim against Xstrata brought on behalf of group of Peruvian citizens who suffered significant harm during a public protest regarding the impact of the mine on their local community.
He has previously jointly led a team of lawyers representing over 600 Iraqi citizens who allege they were subjected to unlawful detention and treatment by British Forces in Iraq in the period 2003-2009.
He has worked on a number of the firm’s high-profile international group claims, including claims for compensation brought on behalf of Colombia farmers against BP and Kenyan pastoralists against the MoD for injuries and deaths caused by bombs left on Kenyan land by the British army. He has also worked on a claim for South African gold miners who developed silicosis after being exposed to silica dust.
Post Brexit crystal ball gazing: What the future holds for Phase I Clinical Trials in the UK Clinical Risk 6.4.17
Lawyers repeat call for a public inquiry (sheep dip controversy) Farmers Mart Magazine August/September 2016